Mechanism of tissue-specific farnesoid X receptor in suppressing the expression of genes in bile-acid synthesis in mice

Cited by (457)

Items 301–400 of 457

1. The Orphan Nuclear Receptor Gene NR0B2 Is a Favorite Prognosis Factor Modulated by Multiple Cellular Signal Pathways in Human Liver Cancers
   Runzhi Zhu, Yanjie Tu, Jingxia Chang, Haixia Xu, Jean C. Li, Wang Liu, Ahn-Dao Do, Yuxia Zhang, Jinhu Wang, Benyi Li · 2021 · Frontiers in Oncology
2. Succinate communicates pro-inflammatory signals to the host and regulates bile acid enterohepatic metabolism in a pig model
   Xuan Li, Yuting Ren, Guowen Huang, Ruofan Zhang, Yanan Zhang, Weiyun Zhu, Kaifan Yu · 2022 · Food & Function
3. Suppression of SIRT1/FXR signaling pathway contributes to oleanolic acid-induced liver injury
   Songjie Liao, Xiaolong Fu, Jianxiang Huang, Yi Wang, Yuan‐Fu Lu, Shaoyu Zhou · 2023 · Toxicology and Applied Pharmacology
4. Circadian PER1 controls daily fat absorption with the regulation of PER1-PKA on phosphorylation of bile acid synthetase
   Wenhao Ge, Qi Sun, Yunxia Yang, Zhao Ding, Junhao Liu, Jianfa Zhang · 2023 · Journal of Lipid Research
5. Nuclear Receptor Control of Enterohepatic Circulation
   Frank J. Gonzalez · 2012 · Comprehensive physiology
6. Polygoni multiflori radix exacerbates idiosyncratic inflammatory liver injury through the FXR-SHP pathway and altered pharmacokinetic behavior
   Guoqin Zhang, Jianhua Sun, Meiqi Liu, Zhixiang Tian, Zicheng Ma, Bingyu Hao, Jintang Ning, Xiaoliang Ren, Meng Wang, Ping Wang et al. · 2023 · Biomedicine & Pharmacotherapy
7. GDNF-independent ureteric budding: role of PI3K-independent activation of AKT and FOSB/JUN/AP-1 signaling
   James B. Tee, Yohan Choi, Ankur V. Dnyanmote, Marvalyn E. DeCambre, Chiharu Ito, Kevin T. Bush, Sanjay K. Nigám · 2013 · Biology Open
8. Impaired vagus function in rats suppresses bile acid synthesis in the liver by disrupting tight junctions and activating Fxr-Fgf15 signaling in the intestine
   Fangyu Wang, Zhiqiang Lu, Xue Wang, Youcai Zhang · 2017 · Biochemical and Biophysical Research Communications
9. FXR as a pivotal role linking JNK and G0s2 mitigates triptolide-induced hepatotoxicity through the regulation of metabolic disorder of liver
   Qinmei Li, Jian‐Feng Huang, Qi Zhao, Fei Li · 2025 · Pharmacological Research
10. Impact of Inhibiting Ileal Apical versus Basolateral Bile Acid Transport on Cholesterol Metabolism and Atherosclerosis in Mice
    Paul A. Dawson · 2015 · Digestive Diseases
11. Environmental Chemical Contribution to the Modulation of Bile Acid Homeostasis and Farnesoid X Receptor Signaling
    Rulaiha E. Taylor, Anisha Bhattacharya, Grace Liejun Guo · 2021 · Drug Metabolism and Disposition
12. Polygonum multiflorum Thunb suppress bile acid synthesis by activating Fxr-Fgf15 signaling in the intestine
    Jing Wei, Jingrui Chen, Lingling Fu, Lifeng Han, Xiumei Gao, Sarhene Michael, Limin Hu, Youcai Zhang, Guanwei Fan · 2018 · Journal of Ethnopharmacology
13. Characterization of individual bile acids in vivo utilizing a novel low bile acid mouse model
    Rulaiha E. Taylor, Zhenning Yang, Zakiyah R Henry, Gina E Capece, Vik Meadows, Katherine Otersen, Veronia Basaly, Anisha Bhattacharya, Stephanie Mera, Peihong Zhou et al. · 2024 · Toxicological Sciences
14. Effects of intestine-specific deletion of FGF15 on the development of fatty liver disease with vertical sleeve gastrectomy
    Monica D. Chow, Katherine Otersen, Andrew M. Wassef, Bo Kong, Sowmya Yamarthy, Daniel Rizzolo, Ill Yang, Brian Buckley, Alexander Lu, Naomi Crook et al. · 2024 · Hepatology Communications
15. Diet1 Is a Regulator of Fibroblast Growth Factor 15/19-Dependent Bile Acid Synthesis
    Karen Reue, Jessica M. Lee, Laurent Vergnes · 2015 · Digestive Diseases
16. Serum concentration of taurochenodeoxycholic acid predicts clinically significant portal hypertension
    Kateřina Žížalová, Barbora Nováková, Marek Vecka, J Petrtýl, Věra Lánská, Květa Pelinková, Vaclav Smid, Radan Brůha, Libor Vı́tek, Martin Lenicek A · 2022 · Liver International
17. Circadian Clock Control of Hepatic Lipid Metabolism: Role of Small Heterodimer Partner (Shp)
    Li Wang, Suthat Liangpunsakul · 2016 · Journal of Investigative Medicine
18. Impact of Microbiome on Hepatic Metabolizing Enzymes and Transporters in Mice during Pregnancy
    Lyrialle W. Han, Lu Wang, Yuanyuan Shi, Joseph L. Dempsey, Olesya V. Pershutkina, Moumita Dutta, Theo K. Bammler, Julia Yue Cui, Qingcheng Mao · 2020 · Drug Metabolism and Disposition
19. Activation of gut FXR improves the metabolism of bile acids, intestinal barrier, and microbiota under cholestatic condition caused by GCDCA in mice
    Xingming Xie, Bang-Yan Zhang, Shu Ying Feng, Zi-Jun Fan, Guoying Wang · 2025 · Microbiology Spectrum
20. l-Arabinose improves hypercholesterolemia via regulating bile acid metabolism in high-fat-high-sucrose diet-fed mice
    Yu Wang, Jiajia Zhao, Qiang Li, Jinxin Liu, Yujie Sun, Kuiliang Zhang, Mingcong Fan, Haifeng Qian, Yan Li, Li Wang · 2022 · Nutrition & Metabolism
21. Yinchenhao Tang alleviates high fat diet induced NAFLD by increasing NR1H4 and APOA1 expression
    Li Xu, Hongliang Cui · 2023 · Journal of Traditional and Complementary Medicine
22. Characterization of neural stem cells modified with hypoxia/neuron-specific VEGF expression system for spinal cord injury
    Young In Yun, Je-Heon Oh, Yong Wook Kim, G Kim, M Lee, Y Ha · 2017 · Gene Therapy
23. Giardia antagonizes beneficial functions of indigenous and therapeutic intestinal bacteria during protein deficiency
    Aadra Prashant Bhatt, Jason W. Arnold, Muyiwa Awoniyi, Shan Sun, Verônica Feijoli Santiago, Deniz Coskuner, Pedro Henrique Quintela, Kenneth Walsh, Jamie Xiao, Renay Ngobeni et al. · 2024 · Gut Microbes
24. Ursodeoxycholic acid acts as an ileal FXR agonist in male mice with hepatic deficiency of FXR
    Zakiyah R Henry, Syeda Maliha, Veronia Basaly, Zhenning Yang, Rulaiha E. Taylor, Katherine Otersen, Vik Meadows, Daniel Rizzolo, Mary Stofan, Anisha Bhattacharya et al. · 2025 · eGastroenterology
25. FXR agonism protects against liver injury in a rat model of intestinal failure-associated liver disease
    Kiran V.K. Koelfat, Ruben G.J. Visschers, Caroline M.I.M. Hodin, Dirk Rudi de Waart, Wim G. van Gemert, Jack P.M. Cleutjens, Marion J. Gijbels, Ronit Shiri‐Sverdlov, Rajeshwar P. Mookerjee, Kaatje Lenaerts et al. · 2017 · Journal of Clinical and Translational Research
26. Advances in understanding the regulatory mechanism of organic solute transporter α-β
    Zhen-Ning Lu, Hongwei He, Na Zhang · 2022 · Life Sciences
27. Antagonistic Effects of Enrofloxacin on Carbendazim-Induced Developmental Toxicity in Zebrafish Embryos
    Ruiqi Fan, Wanjun Zhang, Jia Li, Sunlin Luo, Ying Liu, Yongpeng Jin, Yongchen Li, Xiaoyan Yuan, Yiqiang Chen · 2021 · Toxics
28. The gut-liver axis in cholangiopathies: focus on bile acid based pharmacological treatment
    Marica Cariello, Raffaella M. Gadaleta, Antonio Moschetta · 2022 · Current Opinion in Gastroenterology
29. Myclobutanil-mediated alteration of liver-gut FXR signaling in mice
    Rulaiha E. Taylor, Laura E. Armstrong, Anisha Bhattacharya, Zakiyah R Henry, Anita Brinker, Brian Buckley, Bo Kong, Grace Liejun Guo · 2022 · Toxicological Sciences
30. Pharmacology and therapeutics of bile acid synthesis and modification enzymes in metabolic diseases
    Lili Ding, Lihua Jin, Wendong Huang · 2026 · Pharmacological Reviews
31. The multiorgan crosstalk network of the liver-brain axis: From molecular mechanisms to emerging therapeutic targets
    Wentao Wang, Yuan-Yuan Xin, Jun-Qiang Niu, Wei-Lin Jin · 2026 · Molecular Aspects of Medicine
32. FXR Friend-ChIPs in the Enterohepatic System
    Vik Meadows, Zhenning Yang, Veronia Basaly, Grace Liejun Guo · 2023 · Seminars in Liver Disease
33. Barley consumption under a high-fat diet suppresses lipogenic genes through altered intestinal bile acid composition
    Kento Mio, Naoko Iida‐Tanaka, Marina Togo‐Ohno, Natsuki Tadenuma, Chiemi Yamanaka, Seiichiro Aoe · 2023 · The Journal of Nutritional Biochemistry
34. Exercise training decreases gene expression of endo- and xeno-sensors in rat small intestine
    Emilienne Tudor Ngo Sock, Zahra Farahnak, Jean-Marc Lavoie · 2014 · Applied Physiology Nutrition and Metabolism
35. Reshaping the gut microbiome and bile acid composition by Gyejibongnyeong-hwan ameliorates western diet-induced dyslipidemia
    So Min Lee, You Mee Ahn, Seonghwan Park, Sarah Shin, Jeeyoun Jung · 2023 · Biomedicine & Pharmacotherapy
36. Modulation of Hepatic Protein Kinase Cβ Expression in Metabolic Adaptation to a Lithogenic Diet
    Wei Huang, Kamal D. Mehta · 2015 · Cellular and Molecular Gastroenterology and Hepatology
37. Discovery of novel and selective farnesoid X receptor antagonists through structure-based virtual screening, preliminary structure-activity relationship study, and biological evaluation
    Xiaodong Dou, Tongyu Huo, Yameng Liu, Zichen Pang, Lingyu Su, Xinyi Zhao, Xing Peng, Zhenming Liu, Liangren Zhang, Ning Jiao · 2024 · European Journal of Medicinal Chemistry
38. Nogo-B inhibition facilitates cholesterol metabolism to reduce hypercholesterolemia
    Chao Xue, Peng Zeng, Ke Gong, Qian Li, Zian Feng, Mengyao Wang, Shasha Chen, Yanfang Yang, Jiaqi Li, Shuang Zhang et al. · 2024 · Cell Reports
39. Ganoderic Acid A Alleviates High‐Fat Diet‐Induced Lipid Metabolism Disorders in Mice by Inhibiting Intestinal Farnesoid X Receptor
    Feng Lu, Shanshan Ju, Ying Yi, Jihan Liu, Chengfeng Yang, Min Li, Hong Zhou, Baoxue Yang · 2025 · Food Frontiers
40. A critical review of natural products driven correction of bile acid dysregulation: a therapeutic strategy for nonalcoholic fatty liver disease
    Qing Peng, Liyuan Hao, Shenghao Li, Fei Yu, Na Li, Xiaoyu Hu · 2025 · Frontiers in Pharmacology
41. FXR in bone metabolism: An emerging regulator
    S M Mahamudul Hassan Rizvi, Shami· Aihemaiti, Yun Kan, Shengxiang Tao, Hui Liu · 2026 · iScience
42. Effects of Overexpression of Fibroblast Growth Factor 15/19 on Hepatic Drug Metabolizing Enzymes
    Daniel Rizzolo, Bo Kong, Stephanie C. Piekos, Liming Chen, Xiao‐bo Zhong, Jie Li Lu, Jian Shi, Hao‐Jie Zhu, Qian Yang, Albert P. Li et al. · 2021 · Drug Metabolism and Disposition
43. Conjugated Bile Acids Promote Lymphangiogenesis by Modulation of the Reactive Oxygen Species–p90RSK–Vascular Endothelial Growth Factor Receptor 3 Pathway
    Priyanka Banerjee, Subhashree Kumaravel, Sukanya Roy, Niyanshi Gaddam, Johnny Odeh, Kayla J. Bayless, Shannon S. Glaser, Sanjukta Chakraborty · 2023 · Cells
44. Development of Cilofexor, an Intestinally-Biased Farnesoid X Receptor Agonist, for the Treatment of Fatty Liver Disease
    David Hollenback, Eva Hambruch, Gero Fink, Manfred Birkel, Andreas Schulz, Martin Hornberger, Kathy Liu, Kelly MacLennan Staiger, Helen Desiree Krol, Ulrich Deuschle et al. · 2024 · Journal of Pharmacology and Experimental Therapeutics
45. Gypensapogenin A-Liposomes Efficiently Ameliorates Hepatocellular Lipid Accumulation via Activation of FXR Receptor
    Yidan Deng, Jianmei Wang, Di Wu, Lin Qin, Yuqi He, Daopeng Tan · 2024 · Molecules
46. The portal‐drained viscera release fibroblast growth factor 19 in humans
    Kiran V.K. Koelfat, Johanne G. Bloemen, Peter L. M. Jansen, Cornelis H.C. Dejong, Frank G. Schaap, Steven W.M. Olde Damink · 2016 · Physiological Reports
47. Effects of absence of Constitutive Androstane Receptor (CAR) on bile acid homeostasis in male and female mice
    Lickteig, Andrew J, Zhang, Youcai, Klaassen, Curtis D, Csanaky, Iván L · 2019 · Toxicological Sciences
48. Loss of toll-like receptor 5 potentiates spontaneous hepatocarcinogenesis in farnesoid X receptor–deficient mice
    Rachel M. Golonka, Beng San Yeoh, Piu Saha, Amira F. Gohara, Ramakumar Tummala, Stanislaw M. Stepkowski, Amit Kumar Tiwari, Bina Joe, Frank J. Gonzalez, Andrew T. Gewirtz et al. · 2023 · Hepatology Communications
49. Fibroblast growth factor 21 ameliorates cholestatic liver injury via a hepatic FGFR4-JNK pathway
    Chuanren Zhou, Xiaomin Pan, Lei Huang, Tianzhen Wu, Tiantian Zhao, Jie Qi, Jiamin Wu, Alan Vengai Mukondiwa, Yuli Tang, Yongde Luo et al. · 2023 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
50. Lactobacillus rhamnosus GG-derived extracellular vesicles improve cholestatic liver injury by regulating the gut microbiota and bile acid metabolism
    Zhongyu Wang, Yubo Wang, Yawei Qiu, Ana Isabel Vigil Medina, Yongwang Liu, Mengdie Shi, Jinyan Li, Yanyan Wang, Xianjiao Liu, Xingxiang Chen et al. · 2025 · Chemical Engineering Journal
51. Abcb4-defect cholangitis mouse model with hydrophobic bile acid composition by in vivo liver-specific gene deletion
    Kota Tsuruya, Keiko Yokoyama, Yusuke Mishima, Kinuyo Ida, Takuma Araki, Satsuki Ieda, Masato Ohtsuka, Yutaka Inagaki, Akira Honda, Tatehiro Kagawa et al. · 2024 · Journal of Lipid Research
52. Transcriptome-based analysis reveals the toxic effects of perfluorononanoic acid by affecting the development of the cardiovascular system and lipid metabolism in zebrafish
    Ming Qian, Weiqiang Sun, Lin Cheng, Yuanyuan Wu, Wang Li, Hui Liu · 2024 · Comparative Biochemistry and Physiology Part C Toxicology & Pharmacology
53. Research progress on the hepatoprotective effect, pharmacokinetic properties, and hepatotoxicity of geniposide
    Songyuan Tang, Guangli Yan, Ling Dong Kong, Hui Juan Sun, Chang Liu, Ying Mei Han, Xijun Wang · 2025 · Acupuncture and Herbal Medicine
54. Bridging cell surface receptor with nuclear receptors in control of bile acid homeostasis
    Shuangwei Li, Andrew Ni, Gen‐Sheng Feng · 2014 · Acta Pharmacologica Sinica
55. Bile acids and metabolic surgery
    Hui Xue, Luyao Huang, Jui Tu, Lili Ding, Wendong Huang · 2021 · Liver Research
56. miR-199a-5p inhibits the expression of ABCB11 in obstructive cholestasis
    Natarajan Balasubramaniyan, Michael W. Devereaux, David J. Orlicky, Ronald J. Sokol, Frederick J. Suchy · 2021 · Journal of Biological Chemistry
57. Chronic activation of FXR-induced liver growth with tissue-specific targeting Cyclin D1
    Weibin Wu, Qing Wu, Xin-Mei Liu · 2019 · Cell Cycle
58. Gentamicin alleviates cholestatic liver injury by decreasing gut microbiota-associated bile salt hydrolase activity in rats
    Yanrong Ma, Huan Wang, Jinru Yang, Mingyan Xin, Xinan Wu · 2023 · European Journal of Pharmacology
59. Liver-specific Nr1h4 deletion in mice with human-like bile acid composition causes severe liver injury
    Yusuke Mishima, Kota Tsuruya, Kinuyo Ida, Satsuki Ieda, Yutaka Inagaki, Akira Honda, Tatehiro Kagawa, Akihide Kamiya · 2025 · Journal of Lipid Research
60. Lactiplantibacillus plantarum Lp20 Alleviates High Fat Diet-Induced Obesity in Mice via Its Bile Salt Hydrolase Activity
    Xi Bai, Fangzhou Lu, Yizhi Jing, Hui Wang, Haidong Qian, Ming Zhang, Zhengyuan Zhai, Yanling Hao · 2025 · Nutrients
61. Bile acids as gatekeepers: Orchestrating gut-liver axis for metabolic and immune balance
    Qiang Chen, Xin LIU, Zi-Hao Jiang · 2026 · Hepatobiliary & pancreatic diseases international
62. Bile acid signaling, metabolism, and aging
    Ji Sun, Shili Zhang, Lihua Jin, Wendong Huang · 2026 · Liver Research
63. Network Pharmacology Analysis Reveals Multi-Target Hepatoprotective Mechanisms of a Multi-Component Pharmacopuncture Against Ephedra-Associated Liver Injury with Implications for Mitochondrial Quality Control
    Ji Hye Hwang, Chul Jung · 2026 · Medicina
64. Effects of patent ductus venosus on bile acid homeostasis in aryl hydrocarbon receptor (AhR)-null mice
    Iván L. Csanaky, Andrew J. Lickteig, Youcai Zhang, Curtis D. Klaassen · 2020 · Toxicology and Applied Pharmacology
65. Assessment of fibroblast growth factor 19 as a non-invasive serum marker for hepatocellular carcinoma
    Ghada Abdelrahman Mohamed, Ehab Hasan Nashaat, Hadeer Mohamed Fawzy, Ahmed Mohamed ElGhandour · 2022 · World Journal of Hepatology
66. Hepatocyte-specific Sox9 knockout ameliorates acute liver injury by suppressing SHP signaling and improving mitochondrial function
    Dan Qin, Rui Wang, Jinwei Ji, Duo Wang, Yuanyuan Lu, Shiyao Cao, Yaqing Chen, Liqiang Wang, Xiangmei Chen, Lisheng Zhang · 2023 · Cell & Bioscience
67. Predictive value of serum fibroblast growth factor 19 and liver stiffness for intestinal failure associated liver disease-cholestasis
    Yaqin Xiao, Gulisudumu Maitiabula, Haoyang Wang, Kangjing Xu, Yupeng Zhang, Niannian Fu, Li Zhang, Tingting Gao, Guangming Sun, Deshuai Song et al. · 2023 · Clinical Nutrition ESPEN
68. FGL2 improves experimental colitis related to gut microbiota structure and bile acid metabolism by regulating macrophage autophagy and apoptosis
    Yuan Zhao, Zheng Xiang, Haoran Pan, Xielin Huang, Weizhen Chen, Zhiming Huang · 2024 · Heliyon
69. Manipulating the Microbiome: An Alternative Treatment for Bile Acid Diarrhoea
    Evette B. M. Hillman, Sjoerd G. T. Rijpkema, Danielle Carson, Ramesh Pulendran Arasaradnam, Elizabeth M. H. Wellington, Gregory C. A. Amos · 2021 · Microbiology Research
70. Berberine reverses LPS-induced repression of CYP7A1 through an anti-inflammatory effect
    Bei Cao, Runbin Sun, Yan Geng, Guang‐Yu Yang, Jiye Aa, Juan Li · 2019 · Chinese Herbal Medicines
71. Reversing metabolic dysregulation in farnesoid X receptor knockout mice via gut microbiota modulation
    Ines L. Paraiso, Armando Alcázar Magaña, Alexandra Alexiev, Thomas J. Sharpton, Claudia S. Maier, Chrissa Kioussi, Jan Frederik Stevens · 2025 · PLoS ONE
72. Effects of intestine-specific deletion of fibroblast growth factor 15 on alcoholic liver disease development in mice
    B. Kong, Ming-Xing Huang, Rulaiha E. Taylor, D. Rizzolo, Katherine Otersen, Grace L. Guo · 2022 · Liver Research
73. Host response to cholestyramine can be mediated by the gut microbiota
    Nolan K. Newman, Philip M. Monnier, Richard Rosario Rodrigues, Manoj Gurung, Stephany Vasquez‐Perez, Kaito A. Hioki, Renee L. Greer, Kevin Brown, Andrey Morgun, Natalia Shulzhenko · 2024 · Microbiome Research Reports
74. Nuclear Receptor SHP: A Critical Regulator of miRNA and lncRNA Expression and Function
    Yongfeng Song, Shan Lu, Jiajun Zhao, Li Wang · 2017 · Nuclear Receptor Research
75. Essential role of nuclear receptors for the evaluation of the benefits of bioactive herbal extracts on liver function
    Fengling Wang, Yifan Wu, Xiao‐Ting Xie, Jing Sun, Weidong Chen · 2018 · Biomedicine & Pharmacotherapy
76. Repression of Organic Anion Transporting Polypeptide (OATP) 1B Expression and Increase of Plasma Coproporphyrin Level as Evidence for OATP1B Downregulation in Cynomolgus Monkeys Treated with Chenodeoxycholic Acid
    Yueping Zhang, Shen-Jue Chen, Cliff Chen, Xueqing Chen, Sagnik Chatterjee, David J. Shuster, Heather Dexter, Laura E. Armstrong, Elizabeth Joshi, Zheng Yang et al. · 2022 · Drug Metabolism and Disposition
77. Licraside as novel potent FXR agonist for relieving cholestasis: structure-based drug discovery and biological evaluation studies
    Lili Xi, Axi Shi, Tiantian Shen, Guoxu Wang, Yuhui Wei, Jingjing Guo · 2023 · Frontiers in Pharmacology
78. Molecular Mechanisms Involved in MAFLD in Cholecystectomized Patients: A Cohort Study
    Shreya C. Pal, Stephany M. Castillo-Castañeda, Luis E. Díaz-Orozco, Mariana Michelle Ramírez-Mejía, Rita Dorantes-Heredia, Rogelio Alejandro Alonso-Morales, Mohammed Eslam, Frank Lammert, Nahúm Méndez‐Sánchez · 2023 · Genes
79. Cholestyramine alters bile acid amounts and the expression of cholesterol-related genes in rabbit intestinal and hepatic tissues
    Qiu, Dong Ni, Shang, Quan, Sun, Da Yu, Ding, Wei Qun, Luo, Zhong Guang, Chen, Jian, Jiang, Wei Ru, Huang, Jian Ping, Jiang, Xiao Yun · 2017 · Journal of Digestive Diseases
80. Bile acid accumulation induced by miR-122 deficiency in liver parenchyma promotes cancer cell growth in hepatocellular carcinoma
    Jia-Hui Huang, Yi-Hang Li, Jinhui Hong, Ruonan Li, Ruizhi Wang, Zi-Qi Chen, Songyang Li, Ying-Lei Chi, Jinyu Huang, Ying Zhu · 2025 · Molecular Therapy — Nucleic Acids
81. Changes in the FXR-cistrome and alterations in bile acid physiology in Wilson disease
    Clavia Ruth Wooton‐Kee, Hari Krishna Yalamanchili, Islam B. Mohamed, Manal M. Hassan, Kenneth D.R. Setchell, Mónica Narváez-Rivas, Ayse Kubra Coskun, Vasanta Putluri, Nagireddy Putluri, Prasun K. Jalal et al. · 2025 · Hepatology Communications
82. Recent advances in the modulatory effects and mechanisms of food-derived polysaccharides on hepatic lipid metabolic dysfunction
    Yue Zhang, Qing Chen, Zhi Ouyang, Hao Dong, Chao Li, Xiong Fu · 2025 · International Journal of Biological Macromolecules
83. Intestinal-restricted farnesoid X receptor agonist Fex3 alleviates cholestatic liver injury via FGF15-CYP7A1 axis
    Jiangzhou Song, Yi Wang, Rongrong Guo, K Y Wang, Yang Hu, Ming Cui, Guangji Wang, Haiping Hao, Hong Wang, Xiaowei Xu · 2026 · European Journal of Pharmacology
84. Partial liver resection alters the bile salt-FGF19 axis in patients with perihilar cholangiocarcinoma: Implications for liver regeneration
    Kiran V.K. Koelfat, Frank G. Schaap, Kim M.C. van Mierlo, Martin Lenicek A, Ilka Sauer, Gregory van der Kroft, Anjali A. Roeth, Jan Bednarsch, Iakovos Amygdalos, Georg Lurje et al. · 2024 · Hepatology Communications
85. Bile Acid Profiling in Mouse Biofluids and Tissues
    Bo Kong, Daniel Rizzolo, Rulaiha E. Taylor, Grace Liejun Guo · 2022 · Methods in molecular biology
86. Transcriptomic landscape of Hras12V oncogene-induced hepatocarcinogenesis with gender disparity
    Huaiyuan Di, Zhuona Rong, Nan Mao, Huiling Li, Jun Chen, Renwu Liu, Aiguo Wang · 2025 · BMC Cancer
87. Farnesoid X receptor‑driven metabolic plasticity: Bridging physiological adaptation and malignant transformation in lipid handling (Review)
    Yanning Sun, Kai Sun, Hongju Ling, Qinghua Xia · 2025 · International Journal of Molecular Medicine
88. Copper-mediated shifts in transcriptomic responses of intestines in Bufo gargarizans tadpoles to lead stress
    Siliang Zhang, Aixia Chen, Ling Jiang, Xiaoli Liu, Lihong Chai · 2023 · Environmental Science and Pollution Research
89. Giardia Antagonizes Beneficial Functions of Indigenous and Therapeutic Intestinal Bacteria during Malnutrition
    Aadra Prashant Bhatt, Jason W. Arnold, Muyiwa Awoniyi, Shan Sun, Verônica Feijoli Santiago, Pedro Henrique Quintela, Kenneth Walsh, Renay Ngobeni, Brenna Hansen, Ajay Gulati et al. · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
90. Glucagon-like peptide-2 pharmacotherapy activates hepatic Farnesoid X receptor-signaling to attenuate resection-associated bile acid loss in mice
    Johannes Reiner, Nooshin Mohebali, Jens Kurth, Maria B. Witte, Cornelia P. Prehn, Tobias Lindner, Peggy Berlin, Nagi Elleisy, Robert H. Förster, Alexander Cecil et al. · 2025 · Molecular Metabolism
91. Fibroblast growth factor 15 overexpression and combined peroxisome proliferator–activated receptor α activation attenuates metabolic dysfunction–associated steatohepatitis progression in mice
    Hong Qi Shi, Mary Stofan, Bo Kong, Rulaiha E. Taylor, Zakiyah R Henry, Syeda Maliha, Daniel Rizzolo, Grace Liejun Guo · 2025 · Drug Metabolism and Disposition
92. Genipin ameliorates cholestatic liver injury in Mdr2−/− mice: the role of gut microbiota modulation by its dialdehyde intermediates
    Junli Jin, Lulu Zhu, Chengjiang He, Haiping Deng, Ni Li, Hong Pan, Fuguo Shi · 2026 · Toxicology and Applied Pharmacology
93. Maternal probiotic and prebiotic supplementation on glucose metabolism in pregnant women and their offspring: effects and related mechanisms
    Hanmo Lin, Chuhan Shao, Jie Yu, Haiyan Chen, Yaolin Ren, Jing Ren, Yuan Zeng, Yifan Wu, Qian Zhang, Xinhua Xiao · 2026 · Frontiers in Microbiology
94. Bile acid signaling: from dynamic pool composition to inter-organ communication
    Fuyu Yang, Ting Wei, K L Liu, Huikuan Chu, Ling Yang · 2026 · Frontiers in Endocrinology
95. Therapeutic Potential of Danyankang Capsule in High-Fat Diet-Induced Cholelithiasis and Its Impact on Liver FXR Signaling and Gut Microbiota
    Lin Zhou, Chu-Ling Zhang, Kun Jiang, Hongyu Cheng, Wen-Wen Xiong, Ji‐Xiao Zhu · 2024 · Biological and Pharmaceutical Bulletin
96. Long-term effects of Nε-carboxymethyllysine intake on intestinal barrier permeability: Associations with gut microbiota and bile acids
    Xin Qiang, Xiaoyuan Wang, Shumin Liang, Shaogang Li, Yinchuan Lv, Jing Zhan · 2024 · Food Research International
97. The mood stabilizers lithium and valproate disrupt hepatic and intestinal farnesoid X receptor signalling and increase bile synthesis in the rat
    Sofia Cussotto, Anna V. Golubeva, Alvaro Lopez Gallardo, Thomaz F. S. Bastiaanssen, Alexander V. Zhdanov, Gerard M. Moloney, Caitríona Scaife, Jane A. English, Susan A. Joyce, Timothy G. Dinan et al. · 2025 · Experimental Physiology
98. Key Transcription Factors: Avenue for Treating Alcoholic Liver Disease
    Min Guo, Jian-Nan Cao, Xiaodong Li, Ling Jin · 2025 · Current Medical Science
99. The role of fibroblast growth factors in cell and cancer metabolism
    Jessica Price, Chiara Francavilla · 2025 · FEBS Letters
100. Bile acid flux through portal but not peripheral veins inhibits CYP7A1 expression without involvement of ileal FGF19 in rabbits
     Quan Shang, Grace Liejun Guo, Akira Honda, Daniel W. Shi, Monica Saumoy, Gerald Salen, Guorong Xu · 2014 · American Journal of Physiology-Gastrointestinal and Liver Physiology